WHO vaccine-preventable diseases: monitoring system. 2013 global summary

Last updated 20-Octl-2013 (data as of 16-Oct-2013)
Next overall update June 2014
EPI mother and child logo         
Select a country

Development status: Least developed GNI / capita (US$): 1 Infant (under 12 months) mortality rate: 732
GDP / capita (US$): 1 Child (under 5 years) mortality rate: 1012

Population data in thousands3

  2012  2011  2010  2009  2008  2000  1990  1980 
Total population 29'825  29'105  28'398  27'708  27'032  20'595  11'731  13'180 
Births 1'053  1'066  1'079  1'092  1'103  1'048  643  657 
Surviving infants 981  991  1'001  1'011  1'018  948  560  543 
Pop. less than 5 years 4'964  5'010  5'030  5'036  5'028  4'263  2'301  2'511 
Pop. less than 15 years 14'136  13'990  13'802  13'567  13'296  10'187  5'708  6'161 
Female 15-49 years 6'527  6'280  6'054  5'857  5'681  4'277  2'509  2'888 

Number of reported case

(Click for retrospective incidence data for Afghanistan)
Diphtheria 84  368  1'939 
Japanese encephalitis
Measles 2'787  3'013  1'989  2'861  1'599  6'532  1'609  32'455 
Mumps
Pertussis 1'497  2'448  896  411  15'748 
Polio* 46  81  30  38  31  120  48  880 
Rubella 750  46  501  415 
Rubella (CRS)
Tetanus (neonatal) 21  20  23  12  139  16 
Tetanus (total) 37  20  23  19  57  131  1'618 
Yellow fever
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV);"
"it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Afghanistan)
Vaccine year result method % card seen                                                
BCG 2010  64  MICS   30.6  89  83  68  64  66  30  30  33 
DTP1 2010  58  MICS   30.6  99*  94  86  84  85  48 
DTP3 2010  40  MICS   30.6  87  82  66  63  64  24  25 
HepB_BD         
HepB3          87  82  66  63  64 
Hib3          87  82  66  63 
JapEnc         
MCV 2010  56  MICS   30.6  81  75  62  60  59  27  20  11 
MCV2          54  48  46  40  39 
PCV1         
PCV3         
Pol3 2010  48  MICS   30.6  87  82  66  63  64  24  25 
Rota1         
Rota_last         
Rubella1         
TT2plus 2007  33     34.0  76  75  65  68  65  20 
PAB         
VAD1          15 
YFV         
  ° indicates that more than 1 survey occurred that year

  Next update: July 2014

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Afghanistan)
BCG 75  71  68  64  66  30  30 
DTP1 86  86  86  84  85  48  50  22 
DTP3 71  68  66  63  64  24  25 
HepB3 71  68  66  63  64 
Hib3 71  68  66  63 
MCV 68  65  62  60  59  27  20  11 
PAB 60  60  79  89  83  32  13 
PCV3
Pol3 71  68  66  63  64  24  25 
Rota_last

Number of districts in the country 329  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
98 
   
/
|
|
\
Greater or equal to 90% 47
From 80 to 89% 13
From 50 to 79% 28
Less than 50% 12
Proportion of districts
not reporting DTP3 coverage
0
 

Immunization Schedule (2012 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG birth; Yes
DTwPHibHepB 6, 10, 14 weeks; Yes
Measles 9, 18 months; Yes
OPV birth; 6, 10, 14 weeks; 9 months; Yes
Pneumo_conj 6, 10, 14 weeks; Yes From August 2013
TT 1st contact; +1, +6 months; +1, +1 year; Yes CBAW

Immunizaton indicators

Indicator Expected answer 2012  2011  2010  2009  2008  2007  2006 

Planning and management

Multi-year plan (MYP) for immunization Yes/No/NR Yes  Yes  Yes  Yes  Yes  Yes  Yes 
What years does the MYP cover? number 2011-2015  2011-2015  2010-2015  2006-2010  2006-2010  2006-2010  2006-2010 
Nº of districts with microplans that include activities to raise immunization coverage number 321  321  321  324  324   

National Immunization Advisory Mechanism

Does the country have a standing technical advisory group on immunization? Yes/No/NR Yes  Yes  Yes         

System performance

Total number of districts in country number 329  329  329  329  329  329  329 
Nº districts with DTP3 coverage >=80% number 195  187  190  185  191  180   
% of districts with DTP3 coverage >=80% From 0 to 100% 59  57  58  56  58  55   
Nº districts with measles (MCV1) coverage >=95% number 111  99  93  68  67     
% of districts with MCV1 coverage >=95% From 0 to 100% 34  30  28  21  20     

Safety

Monitoring of Adverse Events Following Immunization (AEFI)? Yes/No/NR No  No    Yes  Yes  Yes  Yes 
Does your country have a vaccine adverse events review committee? Yes/No/NR/ND No  No  No         

Finance

Percentage of routine vaccines funded by Government From 0 to 100%   10 

Maternal and neonatal tetanus (NT) elimination

NT eliminated Yes/No No  No  No  No  No  No  No 

Sources

Unless otherwise specified, data provided by Member States through WHO-UNICEF Joint Reporting Form and WHO Regional offices.
 1  "The 2013 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2012, data for 2011
 3  "United Nations, Population Division. The World Population Prospects - the 2012 revision". New York, 2013.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.